IL-10/NN
inhibits/VBZ
nuclear/JJ
factor-kappa/NN
B/Rel/NN
nuclear/JJ
activity/NN
in/IN
CD3-stimulated/JJ
human/JJ
peripheral/JJ
T/NN
lymphocytes/NNS
./.

IL-10/NN
markedly/RB
reduces/VBZ
nuclear/JJ
factor/NN
(/(
NF/NN
)/)
-kappa/NN
B/Rel/NN
nuclear/JJ
activity/NN
induced/VBN
in/IN
PBMC/NN
by/IN
stimulation/NN
with/IN
the/DT
anti-CD3/JJ
mAb/NN
OKT3/NN
./.
=====
The/DT
inhibition/NN
is/VBZ
exerted/VBN
specifically/RB
on/IN
the/DT
NF-kappa/NN
B/Rel/NN
activation/NN
induced/VBN
by/IN
mAb/NN
OKT3/NN
,/,
and/CC
not/RB
that/DT
produced/VBN
by/IN
PMA/NN
./.
=====
As/IN
judged/VBN
by/IN
supershifting/VBG
the/DT
DNA-protein/JJ
complexes/NNS
with/IN
Abs/NN
recognizing/VBG
specific/JJ
components/NNS
of/IN
the/DT
NF-kappa/NN
B/Rel/NN
protein/NN
family/NN
,/,
the/DT
p50/p65/NN
(/(
Rel/NN
A/NN
)/)
heterodimeric/JJ
form/NN
of/IN
NF-kappa/NN
B/NN
is/VBZ
primarily/RB
affected/VBN
./.
=====
The/DT
maximal/JJ
effect/NN
is/VBZ
observed/VBN
at/IN
the/DT
IL-10/NN
concentration/NN
of/IN
20/CD
U/ml/NN
./.
=====
IL-10/NN
inhibitory/JJ
activity/NN
is/VBZ
exerted/VBN
on/IN
T/NN
lymphocytes/NNS
and/CC
is/VBZ
mediated/VBN
by/IN
monocytes/NNS
./.
=====
Indeed/RB
,/,
monocytes/NNS
pretreated/VBN
with/IN
IL-10/NN
are/VBP
able/JJ
so/RB
inhibit/VBP
NF-kappa/NN
B/NN
nuclear/JJ
activity/NN
in/IN
purified/VBN
T/NN
lymphocytes/NNS
stimulated/VBN
with/IN
OKT3/NN
./.
=====
Soluble/JJ
factors/NNS
do/VBP
not/RB
appear/VB
to/TO
be/VB
involved/VBN
in/IN
the/DT
mechanism/NN
of/IN
inhibition/NN
./.
=====
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
up-regulation/NN
of/IN
CD80/NN
Ag/NN
,/,
found/VBN
on/IN
monocytes/NNS
obtained/VBN
from/IN
PBMC/NN
incubated/VBN
with/IN
OKT3/NN
,/,
is/VBZ
not/RB
detected/VBN
after/IN
addition/NN
of/IN
IL-10/NN
,/,
and/CC
the/DT
anti-CD28/JJ
mAb/NN
CLB-CD28/1/NN
restores/VBZ
the/DT
NF-kappa/NN
B/Rel/NN
nuclear/JJ
activity/NN
in/IN
IL-10-inhibited/JJ
lymphocytes/NNS
./.
=====
Therefore/RB
,/,
the/DT
NF-kappa/NN
B/Rel/NN
inhibition/NN
might/MD
be/VB
ascribed/VBN
to/TO
a/DT
lack/NN
of/IN
cooperation/NN
between/IN
accessory/NN
cells/NNS
and/CC
T/NN
lymphocytes/NNS
,/,
resulting/VBG
from/IN
down-regulation/NN
of/IN
a/DT
costimulatory/JJ
molecule/NN
,/,
such/JJ
as/IN
CD80/NN
,/,
produced/VBN
by/IN
IL-10/NN
on/IN
activated/VBN
monocytes/NNS
./.
=====
Our/PRP$
results/NNS
demonstrate/VBP
that/IN
IL-10/NN
can/MD
inhibit/VB
the/DT
induction/NN
of/IN
NF-kappa/NN
B/Rel/NN
nuclear/JJ
activity/NN
in/IN
CD3-stimulated/JJ
T/NN
lymphocytes/NNS
./.
=====
Since/IN
inappropriate/JJ
activation/NN
of/IN
kappa/NN
B-driven/JJ
genes/NNS
has/VBZ
a/DT
physiopathologic/JJ
role/NN
in/IN
a/DT
number/NN
of/IN
diseases/NNS
,/,
such/JJ
as/IN
HIV/NN
infection/NN
,/,
our/PRP$
findings/NNS
support/VBP
the/DT
possibility/NN
of/IN
using/VBG
this/DT
cytokine/NN
to/TO
suppress/VB
an/DT
undesirable/JJ
activation/NN
of/IN
these/DT
transcription/NN
factors/NNS
./.